Compare CRBU & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRBU | ELMD |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.4M | 208.1M |
| IPO Year | 2021 | 2010 |
| Metric | CRBU | ELMD |
|---|---|---|
| Price | $2.38 | $37.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $10.75 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 1.6M | 63.4K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.64 | ★ 46.55 |
| EPS | N/A | ★ 0.91 |
| Revenue | N/A | ★ $54,716,000.00 |
| Revenue This Year | $1.63 | $15.59 |
| Revenue Next Year | $10.93 | $11.51 |
| P/E Ratio | ★ N/A | $43.15 |
| Revenue Growth | N/A | ★ 13.83 |
| 52 Week Low | $0.96 | $17.73 |
| 52 Week High | $3.53 | $39.65 |
| Indicator | CRBU | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 67.29 | 71.63 |
| Support Level | $1.75 | $23.47 |
| Resistance Level | $2.97 | N/A |
| Average True Range (ATR) | 0.17 | 2.70 |
| MACD | 0.03 | 0.35 |
| Stochastic Oscillator | 90.48 | 87.11 |
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.